Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3515)
Palisade Bio, Inc. (PALI)
Williams Donald Allen — Director
Shares
5,000
Price
$1.67
Total Value
$8.36K
Shares Held After
10,728
% of Holdings
46.6%
Immuneering Corp (IMRX)
Brakewood Harold Eugene — Chief Business Officer
Shares
5,250
Price
$4.76
Total Value
$24.99K
Shares Held After
11,050
% of Holdings
47.5%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
1,974
Price
$13.83
Total Value
$27.30K
Shares Held After
3,379,465
% of Holdings
0.1%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
1,995
Price
$13.89
Total Value
$27.70K
Shares Held After
3,379,398
% of Holdings
0.1%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
49
Price
$75.97
Total Value
$3.72K
Shares Held After
318
% of Holdings
13.4%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
9,884
Price
$75.34
Total Value
$744.66K
Shares Held After
41,935
% of Holdings
19.1%
IONIS PHARMACEUTICALS INC (IONS)
Schneider Eugene — EVP, Chf Clinical Develop Ofcr
Shares
9,302
Price
$75.59
Total Value
$703.14K
Shares Held After
63,890
% of Holdings
12.7%
IONIS PHARMACEUTICALS INC (IONS)
O'NEIL PATRICK R. — EVP CLO & General Counsel
Shares
9,191
Price
$75.84
Total Value
$697.05K
Shares Held After
66,171
% of Holdings
12.2%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
44,034
Price
$74.82
Total Value
$3.29M
Shares Held After
224,683
% of Holdings
16.4%
IONIS PHARMACEUTICALS INC (IONS)
Kordasiewicz Holly B. — EVP, Chief Development Officer
Shares
4,141
Price
$75.66
Total Value
$313.31K
Shares Held After
14,718
% of Holdings
22.0%
IONIS PHARMACEUTICALS INC (IONS)
Jenne Kyle — EVP, Chf GL Pdt Str Ofcr
Shares
1,823
Price
$75.96
Total Value
$138.48K
Shares Held After
16,389
% of Holdings
10.0%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
12,922
Price
$75.22
Total Value
$971.99K
Shares Held After
126,307
% of Holdings
9.3%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
8,353
Price
$75.95
Total Value
$634.41K
Shares Held After
26,518
% of Holdings
24.0%
IONIS PHARMACEUTICALS INC (IONS)
Birchler Brian — EVP, Corp and Development Ops
Shares
8,480
Price
$75.11
Total Value
$636.93K
Shares Held After
60,435
% of Holdings
12.3%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
8,977
Price
$75.15
Total Value
$674.62K
Shares Held After
94,757
% of Holdings
8.7%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
1,149
Price
$75.78
Total Value
$87.07K
Shares Held After
4,772
% of Holdings
19.4%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
6,907
Price
$75.75
Total Value
$523.21K
Shares Held After
40,431
% of Holdings
14.6%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
1,358
Price
$20.00
Total Value
$27.16K
Shares Held After
1,007,090
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
1,204
Price
$20.00
Total Value
$24.08K
Shares Held After
891,808
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
1,358
Price
$20.00
Total Value
$27.16K
Shares Held After
1,007,090
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
1,204
Price
$20.00
Total Value
$24.08K
Shares Held After
891,808
% of Holdings
0.1%
ORIC Pharmaceuticals, Inc. (ORIC)
Heyman Richard A. — Director
Shares
3,200
Price
$12.00
Total Value
$38.41K
Shares Held After
213,072
% of Holdings
1.5%
ORIC Pharmaceuticals, Inc. (ORIC)
Heyman Richard A. — Director
Shares
3,500
Price
$12.00
Total Value
$42.02K
Shares Held After
41,800
% of Holdings
7.7%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
20,000
Price
$39.52
Total Value
$790.35K
Shares Held After
40,000
% of Holdings
33.3%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$460.98
Total Value
$23.05K
Shares Held After
320
% of Holdings
13.5%
ONCOLYTICS BIOTECH INC (ONCY)
Seizinger Bernd R. — Director
Shares
100,000
Price
$1.04
Total Value
$103.77K
Shares Held After
466,991
% of Holdings
21.4%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
38,782
Price
$0.54
Total Value
$20.94K
Shares Held After
2,159,860
% of Holdings
1.8%
Exicure, Inc. (XCUR)
Exicure HiTron Inc. — 10% Owner
Shares
734,747
Price
$4.50
Total Value
$3.31M
Shares Held After
1,857,314
% of Holdings
28.3%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
7,521
Price
$37.53
Total Value
$282.23K
Shares Held After
288,976
% of Holdings
2.5%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
61,228
Price
$37.02
Total Value
$2.27M
Shares Held After
296,497
% of Holdings
17.1%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,619
Price
$32.24
Total Value
$84.43K
Shares Held After
1,518
% of Holdings
63.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
4,381
Price
$31.56
Total Value
$138.28K
Shares Held After
4,137
% of Holdings
51.4%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$90.99
Total Value
$181.98K
Shares Held After
0
% of Holdings
100.0%
Immuneering Corp (IMRX)
Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER
Shares
2,298
Price
$4.57
Total Value
$10.50K
Shares Held After
376,496
% of Holdings
0.6%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
200
Price
$27.40
Total Value
$5.48K
Shares Held After
395,575
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
8,300
Price
$26.83
Total Value
$222.65K
Shares Held After
395,775
% of Holdings
2.1%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
136,193
Price
$13.59
Total Value
$1.85M
Shares Held After
3,378,621
% of Holdings
3.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
136,193
Price
$13.58
Total Value
$1.85M
Shares Held After
3,378,546
% of Holdings
3.9%
Harmony Biosciences Holdings, Inc. (HRMY)
Kapadia Sandip — CHIEF FINANCIAL OFFICER
Shares
20,961
Price
$35.92
Total Value
$752.83K
Shares Held After
0
% of Holdings
100.0%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
6,303
Price
$19.89
Total Value
$125.36K
Shares Held After
1,005,732
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
5,590
Price
$19.89
Total Value
$111.18K
Shares Held After
890,604
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
6,303
Price
$19.89
Total Value
$125.36K
Shares Held After
1,005,732
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
5,590
Price
$19.89
Total Value
$111.18K
Shares Held After
890,604
% of Holdings
0.6%
Nkarta, Inc. (NKTX)
HASTINGS PAUL J — Director
Shares
26,046
Price
$2.07
Total Value
$53.92K
Shares Held After
390,023
% of Holdings
6.3%
Nkarta, Inc. (NKTX)
Mahmood Nadir — President
Shares
5,649
Price
$2.07
Total Value
$11.69K
Shares Held After
167,727
% of Holdings
3.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
149
Price
$18.02
Total Value
$2.68K
Shares Held After
213,992
% of Holdings
0.1%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
559
Price
$35.40
Total Value
$19.79K
Shares Held After
97,038
% of Holdings
0.6%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
15,959
Price
$34.72
Total Value
$554.07K
Shares Held After
97,597
% of Holdings
14.1%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
2,111
Price
$33.62
Total Value
$70.98K
Shares Held After
113,556
% of Holdings
1.8%
Immuneering Corp (IMRX)
Schall Thomas J. — Director
Shares
21,645
Price
$4.67
Total Value
$101.04K
Shares Held After
74,530
% of Holdings
29.0%
Showing 2351–2400 of 3515 transactions (page 48 of 71)